Following its 2023 BioRepository Award, Cleveland Clinic’s Head & Neck Institute will make its initial footprint in the newly constructed BioRepository building as it explores the connection between obesity and chronic rhinosinusitis.
Exhalation Delivery System with Fluticasone Offers Greater Benefits than Previously Studied Intranasal Steroids
Novel exhalation delivery system with fluticasone improves outcomes for patients with nasal polyps compared with placebo.
Early Surgical Intervention May Lessen the Need for Postoperative Care and Improve Outcomes in Patients with Chronic Rhinosinusitis
Earlier intervention in chronic rhinosinusitis may become an effective strategy to improve patient outcomes and quality of life and reduce healthcare resource utilization.
Topical Drug Delivery: The New Trend in Maintenance Therapy for Chronic Rhinosinusitis
Topical delivery of medicines for postoperative management of chronic rhinosinusitis is in vogue but patients need to be aware that cold irrigants have potential complications
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy